Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT02319044 · COMPLETED

Trial details

NCT number: NCT02319044
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck

Start date: 2015-04-15
Primary completion: 2016-09-26
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.